Hanlin Gao - Feb 23, 2023 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Chief Scientific Officer
Signature
/s/ Paul Kim as Attorney-in-Fact
Stock symbol
FLGT
Transactions as of
Feb 23, 2023
Transactions value $
-$25,130
Form type
4
Date filed
2/27/2023, 04:16 PM
Previous filing
Feb 17, 2023
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Award $0 +2.14K +0.24% $0.00 908K Feb 23, 2023 Direct F1
transaction FLGT Common Stock Award $0 +12.2K +1.34% $0.00 920K Feb 23, 2023 Direct F2
transaction FLGT Common Stock Tax liability -$25.1K -794 -0.09% $31.65 920K Feb 23, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022.
F2 Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after February 23, 2023, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.
F3 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022.